{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:30:54Z","timestamp":1794958254785,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e34150","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T03:35:05Z","timestamp":1720150505000},"page":"e34150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Deep learning for predicting fibrotic progression risk in diabetic individuals with metabolic dysfunction-associated steatotic liver disease initially free of hepatic fibrosis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4477-0652","authenticated-orcid":false,"given":"Ruihong","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanhua","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2024.e34150_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a State-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34150_bib2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34150_bib3","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","article-title":"Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J. Hepatol."},{"issue":"716","key":"10.1016\/j.heliyon.2024.e34150_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi0759","article-title":"Found in translation\u2014fibrosis in metabolic dysfunction\u2013associated steatohepatitis (MASH)","volume":"15","author":"Wang","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34150_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e34150_bib6","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.3390\/life13122262","article-title":"Non-invasive diagnostic of NAFLD in type 2 diabetes mellitus and risk stratification: strengths and limitations","volume":"13","author":"Boeriu","year":"2023","journal-title":"Life"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34150_bib7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34150_bib8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/gut.2009.205088","article-title":"Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34150_bib9","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"Loomba","year":"2020","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34150_bib10","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34150_bib11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","article-title":"Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34150_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4166\/kjg.2023.071","article-title":"Interpretation of medical images using artificial intelligence: current status and future perspectives","volume":"82","author":"Gong","year":"2023","journal-title":"Korean J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34150_bib13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1148\/radiol.2017171928","article-title":"Liver fibrosis: deep convolutional neural network for staging by using gadoxetic acid\u2013enhanced hepatobiliary phase MR images","volume":"287","author":"Yasaka","year":"2018","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34150_bib14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/gutjnl-2018-316204","article-title":"Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study","volume":"68","author":"Wang","year":"2019","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34150_bib15","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s11548-020-02206-y","article-title":"Deep residual nets model for staging liver fibrosis on plain CT images","volume":"15","author":"Li","year":"2020","journal-title":"Int. J. Comput. Assist. Radiol. Surg."},{"issue":"30","key":"10.1016\/j.heliyon.2024.e34150_bib16","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2024.e34150_bib17","series-title":"Deep Residual Learning for Image Recognition. Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition","year":"2016"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34150_bib18","first-page":"6679","article-title":"TabNet: attentive interpretable tabular learning","volume":"35","author":"Arik","year":"2021","journal-title":"Proc. AAAI Conf. Artif. Intell."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34150_bib19","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1440-1746.2009.05904.x","article-title":"Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis","volume":"24","author":"Park","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34150_bib20","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34150_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/metabo13040517","article-title":"Therapeutic potentials of reducing liver fat in non-alcoholic fatty liver disease: close association with type 2 diabetes","volume":"13","author":"Tsamos","year":"2023","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34150_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34150_bib23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e34150_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J. Diabetes Res."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34150_bib25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/gut.2009.205088","article-title":"Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e34150_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11894-023-00883-8","article-title":"Screening, diagnosis, and staging of non-alcoholic fatty liver disease (NAFLD): application of society guidelines to clinical practice","volume":"25","author":"Ilagan-Ying","year":"2023","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34150_bib27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/flgastro-2021-102064","article-title":"EASL clinical practice guidelines: non-invasive liver tests for evaluation of liver disease severity and prognosis","volume":"13","author":"Archer","year":"2022","journal-title":"Frontline Gastroenterol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34150_bib28","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/hep.31142","article-title":"Serial transient elastography examinations to monitor patients with type 2 diabetes: a prospective cohort study","volume":"72","author":"Lee","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2024.e34150_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.917304","article-title":"Nomogram for quantitatively estimating the risk of fibrosis progression in type 2 diabetic patients with nonalcoholic fatty liver disease: a pilot study","volume":"13","author":"Xia","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e34150_bib30","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/liv.13480","article-title":"Serum biomarkers can predict a change in liver fibrosis 1 year after lifestyle intervention for biopsy-proven NASH","volume":"37","author":"Vilar-Gomez","year":"2017","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34150_bib31","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s10620-016-4079-4","article-title":"Fibrosis assessment in nonalcoholic fatty liver disease (NAFLD) in 2016","volume":"61","author":"Kaswala","year":"2016","journal-title":"Dig. Dis. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34150_bib32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH \u2014 current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34150_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/00365521.2011.634024","article-title":"Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression","volume":"47","author":"Ekstedt","year":"2012","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34150_bib34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/hep.30974","article-title":"Clinical utility of an increase in magnetic resonance elastography in predicting fibrosis progression in nonalcoholic fatty liver disease","volume":"71","author":"Ajmera","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34150_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jgh3.12716","article-title":"Machine learning to predict progression of non-alcoholic fatty liver to non-alcoholic steatohepatitis or fibrosis","volume":"6","author":"Ghandian","year":"2022","journal-title":"JGH Open"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34150_bib36","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1053\/j.gastro.2016.03.008","article-title":"Biopsy and noninvasive methods to assess progression of nonalcoholic fatty liver disease","volume":"150","author":"Bedossa","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34150_bib37","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024101818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024101818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:57:16Z","timestamp":1778885836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024101818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":37,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405844024101818"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34150","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep learning for predicting fibrotic progression risk in diabetic individuals with metabolic dysfunction-associated steatotic liver disease initially free of hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34150"}}